Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-26 @ 3:32 AM
Study NCT ID:
NCT03933618
Status:
COMPLETED
Last Update Posted:
2019-11-18
First Post:
2019-04-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D005058', 'term': 'Eunuchism'}], 'ancestors': [{'id': 'D007006', 'term': 'Hypogonadism'}, {'id': 'D006058', 'term': 'Gonadal Disorders'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000077384', 'term': 'Anastrozole'}, {'id': 'D002996', 'term': 'Clomiphene'}], 'ancestors': [{'id': 'D009570', 'term': 'Nitriles'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D014230', 'term': 'Triazoles'}, {'id': 'D001393', 'term': 'Azoles'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D013267', 'term': 'Stilbenes'}, {'id': 'D001597', 'term': 'Benzylidene Compounds'}, {'id': 'D001555', 'term': 'Benzene Derivatives'}, {'id': 'D006841', 'term': 'Hydrocarbons, Aromatic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'wellivr@amc.edu', 'phone': '518-262-3341', 'title': 'Dr. Charles Welliver', 'organization': 'Albany Medical Center'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'timeFrame': 'Adverse events were collected after the first dose of medication and at the end of week 8, week 16, and week 24 at a participant and provider meeting.', 'description': 'The 6 arms are comprised of certain orders of drug administration. To maintain the integrity of this order, AE have been listed as part of the arm it belongs to. Details regarding when the AE occurred in relation to the drug being administered at that point in time during the arm is listed at the bottom of the table.', 'eventGroups': [{'id': 'EG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 2, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 1, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 1, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 1, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 1, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 1}, {'id': 'EG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap', 'otherNumAtRisk': 4, 'deathsNumAtRisk': 4, 'otherNumAffected': 3, 'seriousNumAtRisk': 4, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'otherEvents': [{'term': 'Headache', 'notes': 'AE occured during anastrazole in both trial arms indicated.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Osteopenia', 'notes': 'Osteopenia AE occurred during anastrazole.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Rib Pain', 'notes': 'AE occured during anastrazole.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Nasal Septal Deviation', 'notes': 'Nasal Septal deviation AE occured during clomiphene.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Left Shoulder Pain', 'notes': 'Left shoulder AE occured during placebo.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Upper Respiratory Infection (URI)', 'notes': 'AE occured during placebo.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Vitamin D deficiency', 'notes': 'AE occured during placebo.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 1}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Dizziness', 'notes': 'AE occured during clomiphene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Insomnia', 'notes': 'AE occured during anastrazole in the trial arms indicated.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Fatigue', 'notes': 'AE occured during clomiphene of both trial arms indicated', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Weight Gain', 'notes': 'AE occured during anastrazole', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Decreased Libido', 'notes': 'AE occured during clomiphene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Bloated', 'notes': 'AE occured during clomiphene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Chronic Maxillary Sinusitis', 'notes': 'AE occured during clomiphene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Right Big Toe Pain', 'notes': 'AE occured during anastrazole', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}, {'term': 'Ringworm', 'notes': 'Ringworm AE occured during clomiphene.', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}], 'seriousEvents': [{'term': 'Lyme Disease', 'notes': 'AE occured during placebo', 'stats': [{'groupId': 'EG000', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 4, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 4, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 4, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT'}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'IIEF (International Index of Erectile Function) Score - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '34', 'groupId': 'OG000'}, {'value': '43', 'groupId': 'OG001'}, {'value': '57', 'groupId': 'OG002'}, {'value': '41', 'groupId': 'OG003'}, {'value': '57', 'groupId': 'OG004'}, {'value': '24', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '57', 'groupId': 'OG000'}, {'value': '57', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}, {'value': '32', 'groupId': 'OG003'}, {'value': '36', 'groupId': 'OG004'}, {'value': '55', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '55', 'groupId': 'OG000'}, {'value': '46', 'groupId': 'OG001'}, {'value': '41', 'groupId': 'OG002'}, {'value': '45', 'groupId': 'OG003'}, {'value': '58', 'groupId': 'OG004'}, {'value': '32', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '50', 'groupId': 'OG000'}, {'value': '52', 'groupId': 'OG001'}, {'value': '55', 'groupId': 'OG002'}, {'value': '47', 'groupId': 'OG003'}, {'value': '18', 'groupId': 'OG004'}, {'value': '62', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'At baseline', 'description': '15 item self reported erectile function. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Total IIEF reported at the initial encounter.'}, {'type': 'PRIMARY', 'title': 'IIEF (International Index of Erectile Function) Score - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '25', 'groupId': 'OG000'}, {'value': '55', 'groupId': 'OG001'}, {'value': '32', 'groupId': 'OG002'}, {'value': '20', 'groupId': 'OG003'}, {'value': '66', 'groupId': 'OG004'}, {'value': '35', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '45', 'groupId': 'OG000'}, {'value': '51', 'groupId': 'OG001'}, {'value': '63', 'groupId': 'OG002'}, {'value': '45', 'groupId': 'OG003'}, {'value': '72', 'groupId': 'OG004'}, {'value': '37', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '55', 'groupId': 'OG000'}, {'value': '59', 'groupId': 'OG001'}, {'value': '32', 'groupId': 'OG002'}, {'value': '65', 'groupId': 'OG003'}, {'value': '43', 'groupId': 'OG004'}, {'value': '28', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '63', 'groupId': 'OG000'}, {'value': '65', 'groupId': 'OG001'}, {'value': '70', 'groupId': 'OG002'}, {'value': '45', 'groupId': 'OG003'}, {'value': '25', 'groupId': 'OG004'}, {'value': '53', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': '15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Total IIEF reported at the end of the first 8 week period'}, {'type': 'PRIMARY', 'title': 'IIEF (International Index of Erectile Function) Score - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '45', 'groupId': 'OG000'}, {'value': '53', 'groupId': 'OG001'}, {'value': '35', 'groupId': 'OG002'}, {'value': '45', 'groupId': 'OG003'}, {'value': '66', 'groupId': 'OG004'}, {'value': '37', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '43', 'groupId': 'OG000'}, {'value': '56', 'groupId': 'OG001'}, {'value': '50', 'groupId': 'OG002'}, {'value': '55', 'groupId': 'OG003'}, {'value': '33', 'groupId': 'OG004'}, {'value': '38', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '53', 'groupId': 'OG000'}, {'value': '62', 'groupId': 'OG001'}, {'value': '37', 'groupId': 'OG002'}, {'value': '58', 'groupId': 'OG003'}, {'value': '59', 'groupId': 'OG004'}, {'value': '15', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '62', 'groupId': 'OG000'}, {'value': '38', 'groupId': 'OG001'}, {'value': '51', 'groupId': 'OG002'}, {'value': '47', 'groupId': 'OG003'}, {'value': '18', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': '15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Total IIEF reported at the end of the second 8 week period - at week 16\n\nData for patient 23 was not collected in the placebo-clomiphene-anastrazole arm.'}, {'type': 'PRIMARY', 'title': 'IIEF (International Index of Erectile Function) Score - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '12', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '42', 'groupId': 'OG002'}, {'value': '52', 'groupId': 'OG003'}, {'value': '65', 'groupId': 'OG004'}, {'value': '41', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '54', 'groupId': 'OG000'}, {'value': '60', 'groupId': 'OG001'}, {'value': '43', 'groupId': 'OG002'}, {'value': '35', 'groupId': 'OG003'}, {'value': '27', 'groupId': 'OG004'}, {'value': '45', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '60', 'groupId': 'OG000'}, {'value': '65', 'groupId': 'OG001'}, {'value': '72', 'groupId': 'OG003'}, {'value': '45', 'groupId': 'OG004'}, {'value': '17', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '52', 'groupId': 'OG000'}, {'value': '59', 'groupId': 'OG001'}, {'value': '60', 'groupId': 'OG002'}, {'value': '47', 'groupId': 'OG003'}, {'value': '14', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': '15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Total IIEF reported at the end of the final 8 week period - at week 24\n\nData was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole'}, {'type': 'SECONDARY', 'title': 'Normalized Testosterone - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '205', 'groupId': 'OG000'}, {'value': '330', 'groupId': 'OG001'}, {'value': '226', 'groupId': 'OG002'}, {'value': '367', 'groupId': 'OG003'}, {'value': '315', 'groupId': 'OG004'}, {'value': '321', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '293', 'groupId': 'OG000'}, {'value': '237', 'groupId': 'OG001'}, {'value': '194', 'groupId': 'OG002'}, {'value': '300', 'groupId': 'OG003'}, {'value': '214', 'groupId': 'OG004'}, {'value': '243', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '347', 'groupId': 'OG000'}, {'value': '328', 'groupId': 'OG001'}, {'value': '268', 'groupId': 'OG002'}, {'value': '206', 'groupId': 'OG003'}, {'value': '321', 'groupId': 'OG004'}, {'value': '148', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '95', 'groupId': 'OG000'}, {'value': '291', 'groupId': 'OG001'}, {'value': '306', 'groupId': 'OG002'}, {'value': '244', 'groupId': 'OG003'}, {'value': '289', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Normalized at \\>350ng/dl', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'Normalized Testosterone measured week 0 - initial screen\n\nData not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Normalized Testosterone - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '484', 'groupId': 'OG000'}, {'value': '757', 'groupId': 'OG001'}, {'value': '566', 'groupId': 'OG002'}, {'value': '1316', 'groupId': 'OG003'}, {'value': '133', 'groupId': 'OG004'}, {'value': '470', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '387', 'groupId': 'OG000'}, {'value': '296', 'groupId': 'OG001'}, {'value': '693', 'groupId': 'OG002'}, {'value': '917', 'groupId': 'OG003'}, {'value': '271', 'groupId': 'OG004'}, {'value': '298', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '607', 'groupId': 'OG000'}, {'value': '453', 'groupId': 'OG001'}, {'value': '216', 'groupId': 'OG002'}, {'value': '527', 'groupId': 'OG003'}, {'value': '270', 'groupId': 'OG004'}, {'value': '139', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '545', 'groupId': 'OG000'}, {'value': '676', 'groupId': 'OG001'}, {'value': '592', 'groupId': 'OG002'}, {'value': '497', 'groupId': 'OG003'}, {'value': '296', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Normalized at \\>350ng/dl', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'Normalized Testosterone measured at the end of the first 8 week period\n\nData for patient 23 was not collected for placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Normalized Testosterone - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '437', 'groupId': 'OG000'}, {'value': '591', 'groupId': 'OG001'}, {'value': '338', 'groupId': 'OG002'}, {'value': '391', 'groupId': 'OG003'}, {'value': '696', 'groupId': 'OG004'}, {'value': '502', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '337', 'groupId': 'OG000'}, {'value': '200', 'groupId': 'OG001'}, {'value': '451', 'groupId': 'OG002'}, {'value': '403', 'groupId': 'OG003'}, {'value': '396', 'groupId': 'OG004'}, {'value': '520', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '329', 'groupId': 'OG000'}, {'value': '191', 'groupId': 'OG001'}, {'value': '124', 'groupId': 'OG002'}, {'value': '206', 'groupId': 'OG003'}, {'value': '585', 'groupId': 'OG004'}, {'value': '283', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '609', 'groupId': 'OG000'}, {'value': '323', 'groupId': 'OG001'}, {'value': '456', 'groupId': 'OG002'}, {'value': '288', 'groupId': 'OG003'}, {'value': '484', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Normalized at \\>350ng/dl', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'Normalized Testosterone measured at the end of the 16th week\n\nData for patient 23 was not collected for placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Normalized Testosterone - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '268', 'groupId': 'OG000'}, {'value': '793', 'groupId': 'OG001'}, {'value': '214', 'groupId': 'OG002'}, {'value': '537', 'groupId': 'OG003'}, {'value': '412', 'groupId': 'OG004'}, {'value': '596', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '269', 'groupId': 'OG000'}, {'value': '519', 'groupId': 'OG001'}, {'value': '440', 'groupId': 'OG002'}, {'value': '531', 'groupId': 'OG003'}, {'value': '375', 'groupId': 'OG004'}, {'value': '972', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '446', 'groupId': 'OG000'}, {'value': '449', 'groupId': 'OG001'}, {'value': '447', 'groupId': 'OG003'}, {'value': '487', 'groupId': 'OG004'}, {'value': '195', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '196', 'groupId': 'OG000'}, {'value': '630', 'groupId': 'OG001'}, {'value': '274', 'groupId': 'OG002'}, {'value': '486', 'groupId': 'OG003'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Normalized at \\>350ng/dl', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'Normalized Testosterone measured at the end of the 24th week\n\nData was not collected for patient 15 clomiphene-anastrazole-placebo Data for patient 23 was not collected for placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene'}, {'type': 'SECONDARY', 'title': 'ADAM (Androgen Deficiency in the Aging Male) Score - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Initial Evaluation for ADAM score - Week 0'}, {'type': 'SECONDARY', 'title': 'ADAM (Androgen Deficiency in the Aging Male) Score - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'ADAM score at the end of Week 8\n\nData was not collected for patient 19 in anastrazole-clomiphene-placebo arm'}, {'type': 'SECONDARY', 'title': 'ADAM (Androgen Deficiency in the Aging Male) Score - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'ADAM score at the end of Week 16 Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'ADAM (Androgen Deficiency in the Aging Male) Score - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'ADAM score at the end of Week 24 No data collected pt 15 in clomiphene-anastrazole-placebo arm no data collected for pt 16 clomiphene-placebo-anastrazole arm no data collected for pt 23 placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'EHS (Erectile Hardness Score) - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Score 0-4 at the initial encounter week 0'}, {'type': 'SECONDARY', 'title': 'EHS (Erectile Hardness Score) - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Score 0-4 at the end of Week 8'}, {'type': 'SECONDARY', 'title': 'EHS (Erectile Hardness Score) - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Score 0-4 at the end of Week 16\n\nData for patient 23 was not collected in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'EHS (Erectile Hardness Score) - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'Score 0-4 at the end of Week 24 no data was collected for patient 15 in clomiphene-anastrazole-placebo no data was collected for patient 23 in placebo-clomiphene-anastrazole'}, {'type': 'SECONDARY', 'title': 'LH - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3.5', 'groupId': 'OG000'}, {'value': '3.6', 'groupId': 'OG001'}, {'value': '3.8', 'groupId': 'OG002'}, {'value': '6.8', 'groupId': 'OG003'}, {'value': '3.5', 'groupId': 'OG004'}, {'value': '3.4', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3.4', 'groupId': 'OG000'}, {'value': '3.8', 'groupId': 'OG001'}, {'value': '2.4', 'groupId': 'OG002'}, {'value': '4.1', 'groupId': 'OG003'}, {'value': '2.4', 'groupId': 'OG004'}, {'value': '1.7', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1.1', 'groupId': 'OG000'}, {'value': '3.5', 'groupId': 'OG001'}, {'value': '4.1', 'groupId': 'OG002'}, {'value': '3.3', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '3.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '6.3', 'groupId': 'OG000'}, {'value': '4.1', 'groupId': 'OG001'}, {'value': '4.7', 'groupId': 'OG002'}, {'value': '5.9', 'groupId': 'OG003'}, {'value': '6.8', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'LH measured at initial encounter\n\nData for pt 23 in placebo-clomiphene-anastrazole not collected'}, {'type': 'SECONDARY', 'title': 'LH - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '9.1', 'groupId': 'OG000'}, {'value': '5.1', 'groupId': 'OG001'}, {'value': '9.9', 'groupId': 'OG002'}, {'value': '17.3', 'groupId': 'OG003'}, {'value': '3.6', 'groupId': 'OG004'}, {'value': '6.3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '5.2', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '10.7', 'groupId': 'OG002'}, {'value': '12.6', 'groupId': 'OG003'}, {'value': '3.3', 'groupId': 'OG004'}, {'value': '1.9', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2.9', 'groupId': 'OG000'}, {'value': '6.9', 'groupId': 'OG001'}, {'value': '6.1', 'groupId': 'OG002'}, {'value': '4.7', 'groupId': 'OG003'}, {'value': '6.7', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '4.2', 'groupId': 'OG000'}, {'value': '11.5', 'groupId': 'OG001'}, {'value': '7.5', 'groupId': 'OG002'}, {'value': '6.9', 'groupId': 'OG003'}, {'value': '7.3', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'LH measured at week 8\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'LH - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '6.8', 'groupId': 'OG000'}, {'value': '4.6', 'groupId': 'OG001'}, {'value': '4.2', 'groupId': 'OG002'}, {'value': '5.4', 'groupId': 'OG003'}, {'value': '13.9', 'groupId': 'OG004'}, {'value': '8.9', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '6.9', 'groupId': 'OG000'}, {'value': '4.8', 'groupId': 'OG001'}, {'value': '6.3', 'groupId': 'OG002'}, {'value': '4.9', 'groupId': 'OG003'}, {'value': '5.2', 'groupId': 'OG004'}, {'value': '3.8', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1.9', 'groupId': 'OG000'}, {'value': '2.1', 'groupId': 'OG001'}, {'value': '2.2', 'groupId': 'OG002'}, {'value': '1.9', 'groupId': 'OG003'}, {'value': '13', 'groupId': 'OG004'}, {'value': '6.4', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '7.8', 'groupId': 'OG000'}, {'value': '4.3', 'groupId': 'OG001'}, {'value': '6.6', 'groupId': 'OG002'}, {'value': '4.9', 'groupId': 'OG003'}, {'value': '7.4', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'LH measured at week 16\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'LH - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '4.1', 'groupId': 'OG001'}, {'value': '3.4', 'groupId': 'OG002'}, {'value': '6.4', 'groupId': 'OG003'}, {'value': '5', 'groupId': 'OG004'}, {'value': '7.7', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '6.1', 'groupId': 'OG000'}, {'value': '12.6', 'groupId': 'OG001'}, {'value': '5.9', 'groupId': 'OG002'}, {'value': '6.4', 'groupId': 'OG003'}, {'value': '2.9', 'groupId': 'OG004'}, {'value': '10.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2.2', 'groupId': 'OG000'}, {'value': '5.4', 'groupId': 'OG001'}, {'value': '7.6', 'groupId': 'OG003'}, {'value': '7.1', 'groupId': 'OG004'}, {'value': '8.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2.7', 'groupId': 'OG000'}, {'value': '15.1', 'groupId': 'OG001'}, {'value': '4.7', 'groupId': 'OG002'}, {'value': '5.4', 'groupId': 'OG003'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'LH measured at week 24\n\nNo data for patient 13 collected in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm'}, {'type': 'SECONDARY', 'title': 'FSH - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2.7', 'groupId': 'OG000'}, {'value': '2.4', 'groupId': 'OG001'}, {'value': '5.5', 'groupId': 'OG002'}, {'value': '4.5', 'groupId': 'OG003'}, {'value': '3.3', 'groupId': 'OG004'}, {'value': '3.6', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '5.7', 'groupId': 'OG000'}, {'value': '3.7', 'groupId': 'OG001'}, {'value': '3.9', 'groupId': 'OG002'}, {'value': '2.9', 'groupId': 'OG003'}, {'value': '1.8', 'groupId': 'OG004'}, {'value': '3.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1.6', 'groupId': 'OG000'}, {'value': '5.1', 'groupId': 'OG001'}, {'value': '1.7', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4.4', 'groupId': 'OG004'}, {'value': '5.7', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '5.5', 'groupId': 'OG000'}, {'value': '10', 'groupId': 'OG001'}, {'value': '4.5', 'groupId': 'OG002'}, {'value': '4.4', 'groupId': 'OG003'}, {'value': '5.1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Lab Values for follicle stimulating hormone', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'FSH measured at initial encounter\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'FSH - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '5.4', 'groupId': 'OG000'}, {'value': '4.3', 'groupId': 'OG001'}, {'value': '8.2', 'groupId': 'OG002'}, {'value': '16.2', 'groupId': 'OG003'}, {'value': '3.4', 'groupId': 'OG004'}, {'value': '4.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '7.7', 'groupId': 'OG000'}, {'value': '6.2', 'groupId': 'OG001'}, {'value': '7.8', 'groupId': 'OG002'}, {'value': '3.03', 'groupId': 'OG003'}, {'value': '2.2', 'groupId': 'OG004'}, {'value': '4.2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '8.3', 'groupId': 'OG001'}, {'value': '1.8', 'groupId': 'OG002'}, {'value': '6.3', 'groupId': 'OG003'}, {'value': '4.7', 'groupId': 'OG004'}, {'value': '6', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '11.3', 'groupId': 'OG000'}, {'value': '20.3', 'groupId': 'OG001'}, {'value': '6.1', 'groupId': 'OG002'}, {'value': '8.1', 'groupId': 'OG003'}, {'value': '4.4', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Lab Values for follicle stimulating hormone', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'FSH measured at Week 8\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'FSH - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '4.3', 'groupId': 'OG001'}, {'value': '4.2', 'groupId': 'OG002'}, {'value': '5.3', 'groupId': 'OG003'}, {'value': '10.7', 'groupId': 'OG004'}, {'value': '6.8', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '7.2', 'groupId': 'OG000'}, {'value': '3.7', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '2.9', 'groupId': 'OG003'}, {'value': '2.6', 'groupId': 'OG004'}, {'value': '6.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '1.9', 'groupId': 'OG000'}, {'value': '3.8', 'groupId': 'OG001'}, {'value': '1.2', 'groupId': 'OG002'}, {'value': '3.3', 'groupId': 'OG003'}, {'value': '8.3', 'groupId': 'OG004'}, {'value': '11.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '12.8', 'groupId': 'OG000'}, {'value': '11.4', 'groupId': 'OG001'}, {'value': '6.2', 'groupId': 'OG002'}, {'value': '4.2', 'groupId': 'OG003'}, {'value': '8.9', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Lab Values for follicle stimulating hormone', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'FSH measured at Week 16\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'FSH - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '4.1', 'groupId': 'OG000'}, {'value': '4.8', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '5.2', 'groupId': 'OG003'}, {'value': '6.5', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '4.4', 'groupId': 'OG000'}, {'value': '15.1', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '3.7', 'groupId': 'OG003'}, {'value': '5.2', 'groupId': 'OG004'}, {'value': '14.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '7.2', 'groupId': 'OG001'}, {'value': '7.2', 'groupId': 'OG003'}, {'value': '5.9', 'groupId': 'OG004'}, {'value': '10.4', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '4.8', 'groupId': 'OG000'}, {'value': '29.7', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '5.8', 'groupId': 'OG003'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Lab Values for follicle stimulating hormone', 'unitOfMeasure': 'IU/L', 'reportingStatus': 'POSTED', 'populationDescription': 'FSH measured at Week 24 Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm'}, {'type': 'SECONDARY', 'title': 'Free Testosterone - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '8.4', 'groupId': 'OG000'}, {'value': '6.99', 'groupId': 'OG001'}, {'value': '7.28', 'groupId': 'OG002'}, {'value': '8.82', 'groupId': 'OG003'}, {'value': '6.27', 'groupId': 'OG004'}, {'value': '7.86', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '6.74', 'groupId': 'OG000'}, {'value': '9.31', 'groupId': 'OG001'}, {'value': '6.07', 'groupId': 'OG002'}, {'value': '9.9', 'groupId': 'OG003'}, {'value': '5.82', 'groupId': 'OG004'}, {'value': '5.78', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '9.56', 'groupId': 'OG000'}, {'value': '12.27', 'groupId': 'OG001'}, {'value': '4.86', 'groupId': 'OG003'}, {'value': '9.49', 'groupId': 'OG004'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2.19', 'groupId': 'OG000'}, {'value': '7.27', 'groupId': 'OG001'}, {'value': '6.52', 'groupId': 'OG002'}, {'value': '7.71', 'groupId': 'OG003'}, {'value': '6.33', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Measure of Free Testosterone', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'FT measured at initial encounter\n\nData was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Free Testosterone - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '19.46', 'groupId': 'OG000'}, {'value': '21.8', 'groupId': 'OG001'}, {'value': '17.72', 'groupId': 'OG002'}, {'value': '35.27', 'groupId': 'OG003'}, {'value': '2.71', 'groupId': 'OG004'}, {'value': '12.3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '15.63', 'groupId': 'OG000'}, {'value': '19.33', 'groupId': 'OG002'}, {'value': '27.79', 'groupId': 'OG003'}, {'value': '9.4', 'groupId': 'OG004'}, {'value': '5.3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '21.61', 'groupId': 'OG000'}, {'value': '15.18', 'groupId': 'OG001'}, {'value': '21.71', 'groupId': 'OG003'}, {'value': '8.91', 'groupId': 'OG004'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '17.44', 'groupId': 'OG000'}, {'value': '20.01', 'groupId': 'OG001'}, {'value': '11.37', 'groupId': 'OG002'}, {'value': '15.71', 'groupId': 'OG003'}, {'value': '6.04', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Measure of Free Testosterone', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'FT measured at the end of Week 8 Data was not collected for patient 8 in anastrazole-placebo-clomiphene arm Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Free Testosterone - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '14.16', 'groupId': 'OG000'}, {'value': '16.37', 'groupId': 'OG001'}, {'value': '12.27', 'groupId': 'OG002'}, {'value': '12.67', 'groupId': 'OG003'}, {'value': '19.21', 'groupId': 'OG004'}, {'value': '17.47', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '8.83', 'groupId': 'OG000'}, {'value': '5.7', 'groupId': 'OG001'}, {'value': '14.7', 'groupId': 'OG002'}, {'value': '9.63', 'groupId': 'OG003'}, {'value': '14.57', 'groupId': 'OG004'}, {'value': '13.47', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '10.17', 'groupId': 'OG000'}, {'value': '5.98', 'groupId': 'OG001'}, {'value': '6.63', 'groupId': 'OG003'}, {'value': '16.38', 'groupId': 'OG004'}, {'value': '7.58', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '14.98', 'groupId': 'OG000'}, {'value': '9.46', 'groupId': 'OG001'}, {'value': '11.22', 'groupId': 'OG002'}, {'value': '11.62', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Measure of Free Testosterone', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'FT measured at the end of Week 16\n\nData was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 22 in clomiphene-placebo-anastrazole arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Free Testosterone - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '10.51', 'groupId': 'OG000'}, {'value': '19.35', 'groupId': 'OG001'}, {'value': '6.25', 'groupId': 'OG002'}, {'value': '11.28', 'groupId': 'OG003'}, {'value': '8.65', 'groupId': 'OG004'}, {'value': '19.31', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '6.11', 'groupId': 'OG000'}, {'value': '11.09', 'groupId': 'OG002'}, {'value': '17.89', 'groupId': 'OG003'}, {'value': '11.63', 'groupId': 'OG004'}, {'value': '25.27', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '11.82', 'groupId': 'OG000'}, {'value': '13.74', 'groupId': 'OG001'}, {'value': '18.19', 'groupId': 'OG003'}, {'value': '15.49', 'groupId': 'OG004'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '5.82', 'groupId': 'OG000'}, {'value': '13.54', 'groupId': 'OG001'}, {'value': '6.11', 'groupId': 'OG002'}, {'value': '16.82', 'groupId': 'OG003'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Measure of Free Testosterone', 'unitOfMeasure': 'ng/dl', 'reportingStatus': 'POSTED', 'populationDescription': 'FT measured at the end of Week 24 Data not collected for patient 8 in APC arm Data was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 18 in placebo-anastrazole-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm No data collected pt 24 in PAC arm'}, {'type': 'SECONDARY', 'title': 'Estradiol - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '21.6', 'groupId': 'OG000'}, {'value': '8.1', 'groupId': 'OG001'}, {'value': '9.6', 'groupId': 'OG002'}, {'value': '13.5', 'groupId': 'OG003'}, {'value': '15.9', 'groupId': 'OG004'}, {'value': '18.4', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '19.3', 'groupId': 'OG001'}, {'value': '21.3', 'groupId': 'OG002'}, {'value': '11.4', 'groupId': 'OG003'}, {'value': '18.6', 'groupId': 'OG004'}, {'value': '10.9', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '13.3', 'groupId': 'OG000'}, {'value': '20.1', 'groupId': 'OG001'}, {'value': '16.2', 'groupId': 'OG002'}, {'value': '14.1', 'groupId': 'OG003'}, {'value': '15.9', 'groupId': 'OG004'}, {'value': '13.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '9.5', 'groupId': 'OG000'}, {'value': '15.5', 'groupId': 'OG001'}, {'value': '26.6', 'groupId': 'OG002'}, {'value': '11', 'groupId': 'OG003'}, {'value': '26.8', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24', 'unitOfMeasure': 'pg/mL', 'reportingStatus': 'POSTED', 'populationDescription': 'Estradiol measurement at initial encounter\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Estradiol - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '11.2', 'groupId': 'OG000'}, {'value': '49.8', 'groupId': 'OG002'}, {'value': '94.5', 'groupId': 'OG003'}, {'value': '20.8', 'groupId': 'OG004'}, {'value': '22.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '15.1', 'groupId': 'OG001'}, {'value': '70.1', 'groupId': 'OG002'}, {'value': '45', 'groupId': 'OG003'}, {'value': '18.5', 'groupId': 'OG004'}, {'value': '9.3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '9.7', 'groupId': 'OG000'}, {'value': '4.9', 'groupId': 'OG001'}, {'value': '25.1', 'groupId': 'OG002'}, {'value': '33.5', 'groupId': 'OG003'}, {'value': '10', 'groupId': 'OG004'}, {'value': '15.9', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '7.4', 'groupId': 'OG000'}, {'value': '10.7', 'groupId': 'OG001'}, {'value': '51.7', 'groupId': 'OG002'}, {'value': '39.1', 'groupId': 'OG003'}, {'value': '27.4', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was \\<5', 'unitOfMeasure': 'pg/mL', 'reportingStatus': 'POSTED', 'populationDescription': 'Estradiol measurement at the end of Week 8\n\nData was not collected for patient 2 in anastrazole-placebo-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Estradiol - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '39.5', 'groupId': 'OG000'}, {'value': '8.9', 'groupId': 'OG002'}, {'value': '17.9', 'groupId': 'OG003'}, {'value': '56.9', 'groupId': 'OG004'}, {'value': '5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '13.1', 'groupId': 'OG000'}, {'value': '21.6', 'groupId': 'OG001'}, {'value': '12.8', 'groupId': 'OG002'}, {'value': '14.4', 'groupId': 'OG003'}, {'value': '28.2', 'groupId': 'OG004'}, {'value': '6.8', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '20.1', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '23.8', 'groupId': 'OG002'}, {'value': '13.1', 'groupId': 'OG003'}, {'value': '37', 'groupId': 'OG004'}, {'value': '4.9', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '48.5', 'groupId': 'OG000'}, {'value': '28.3', 'groupId': 'OG001'}, {'value': '14.8', 'groupId': 'OG002'}, {'value': '15.9', 'groupId': 'OG003'}, {'value': '4.9', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was \\<5', 'unitOfMeasure': 'pg/mL', 'reportingStatus': 'POSTED', 'populationDescription': 'Estradiol measurement at the end of Week 16 Data was not collected for patient 2 in anastrazole-placebo-clomiphene arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'Estradiol - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '22.5', 'groupId': 'OG000'}, {'value': '43.9', 'groupId': 'OG001'}, {'value': '16.2', 'groupId': 'OG002'}, {'value': '9.5', 'groupId': 'OG003'}, {'value': '18.1', 'groupId': 'OG004'}, {'value': '41.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '12.5', 'groupId': 'OG000'}, {'value': '49.1', 'groupId': 'OG001'}, {'value': '6.6', 'groupId': 'OG002'}, {'value': '5', 'groupId': 'OG003'}, {'value': '11.6', 'groupId': 'OG004'}, {'value': '85.9', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '25.5', 'groupId': 'OG000'}, {'value': '36.4', 'groupId': 'OG001'}, {'value': '9.2', 'groupId': 'OG003'}, {'value': '4.9', 'groupId': 'OG004'}, {'value': '29.3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '22.2', 'groupId': 'OG000'}, {'value': '39.4', 'groupId': 'OG001'}, {'value': '19', 'groupId': 'OG002'}, {'value': '4.9', 'groupId': 'OG003'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was \\<5', 'unitOfMeasure': 'pg/mL', 'reportingStatus': 'POSTED', 'populationDescription': 'Estradiol measurement at the end of Week 24\n\nData was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm'}, {'type': 'SECONDARY', 'title': 'SHBG - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '13.9', 'groupId': 'OG000'}, {'value': '35.2', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}, {'value': '31.7', 'groupId': 'OG003'}, {'value': '26.2', 'groupId': 'OG004'}, {'value': '24.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '30.7', 'groupId': 'OG000'}, {'value': '12.6', 'groupId': 'OG001'}, {'value': '23.5', 'groupId': 'OG002'}, {'value': '26.4', 'groupId': 'OG003'}, {'value': '20.9', 'groupId': 'OG004'}, {'value': '26.8', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '23.5', 'groupId': 'OG000'}, {'value': '17.5', 'groupId': 'OG001'}, {'value': '21.4', 'groupId': 'OG002'}, {'value': '20', 'groupId': 'OG003'}, {'value': '16.9', 'groupId': 'OG004'}, {'value': '14.8', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '28.6', 'groupId': 'OG000'}, {'value': '22', 'groupId': 'OG001'}, {'value': '35.5', 'groupId': 'OG002'}, {'value': '11.6', 'groupId': 'OG003'}, {'value': '30.6', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24', 'unitOfMeasure': 'nmol/L', 'reportingStatus': 'POSTED', 'populationDescription': 'SHBG measured at initial encounter\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'SHBG - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '10', 'groupId': 'OG000'}, {'value': '38.2', 'groupId': 'OG001'}, {'value': '18.4', 'groupId': 'OG002'}, {'value': '29.8', 'groupId': 'OG003'}, {'value': '23.9', 'groupId': 'OG004'}, {'value': '21.6', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '23.4', 'groupId': 'OG000'}, {'value': '12.7', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}, {'value': '27.2', 'groupId': 'OG003'}, {'value': '24.1', 'groupId': 'OG004'}, {'value': '25.7', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '26.9', 'groupId': 'OG000'}, {'value': '16.1', 'groupId': 'OG001'}, {'value': '21.6', 'groupId': 'OG002'}, {'value': '30.9', 'groupId': 'OG003'}, {'value': '14.3', 'groupId': 'OG004'}, {'value': '17.6', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '28.1', 'groupId': 'OG000'}, {'value': '20.1', 'groupId': 'OG001'}, {'value': '42.7', 'groupId': 'OG002'}, {'value': '20.9', 'groupId': 'OG003'}, {'value': '30.7', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24', 'unitOfMeasure': 'nmol/L', 'reportingStatus': 'POSTED', 'populationDescription': 'SHBG measured at week 8\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'SHBG - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '22.3', 'groupId': 'OG000'}, {'value': '35.5', 'groupId': 'OG001'}, {'value': '13.8', 'groupId': 'OG002'}, {'value': '16.4', 'groupId': 'OG003'}, {'value': '33.3', 'groupId': 'OG004'}, {'value': '17.7', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '30.7', 'groupId': 'OG000'}, {'value': '15.3', 'groupId': 'OG001'}, {'value': '26.6', 'groupId': 'OG002'}, {'value': '31', 'groupId': 'OG003'}, {'value': '16.7', 'groupId': 'OG004'}, {'value': '23', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '26.8', 'groupId': 'OG000'}, {'value': '17.2', 'groupId': 'OG001'}, {'value': '14.2', 'groupId': 'OG002'}, {'value': '22.8', 'groupId': 'OG003'}, {'value': '17.2', 'groupId': 'OG004'}, {'value': '16.6', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '39.3', 'groupId': 'OG000'}, {'value': '24.8', 'groupId': 'OG001'}, {'value': '35', 'groupId': 'OG002'}, {'value': '13.9', 'groupId': 'OG003'}, {'value': '31', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24', 'unitOfMeasure': 'nmol/L', 'reportingStatus': 'POSTED', 'populationDescription': 'SHBG measured at week 16\n\nData was not collected for patient 23 in placebo-clomiphene-anastrazole arm'}, {'type': 'SECONDARY', 'title': 'SHBG - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '14.6', 'groupId': 'OG000'}, {'value': '41.8', 'groupId': 'OG001'}, {'value': '15.1', 'groupId': 'OG002'}, {'value': '25.2', 'groupId': 'OG003'}, {'value': '29.7', 'groupId': 'OG004'}, {'value': '23.6', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '33.8', 'groupId': 'OG000'}, {'value': '16', 'groupId': 'OG001'}, {'value': '24.4', 'groupId': 'OG002'}, {'value': '25.3', 'groupId': 'OG003'}, {'value': '13.8', 'groupId': 'OG004'}, {'value': '34.1', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '29', 'groupId': 'OG000'}, {'value': '21.7', 'groupId': 'OG001'}, {'value': '20.1', 'groupId': 'OG003'}, {'value': '17.3', 'groupId': 'OG004'}, {'value': '17.5', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '23.2', 'groupId': 'OG000'}, {'value': '26', 'groupId': 'OG001'}, {'value': '33.8', 'groupId': 'OG002'}, {'value': '13.7', 'groupId': 'OG003'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24', 'unitOfMeasure': 'nmol/L', 'reportingStatus': 'POSTED', 'populationDescription': 'SHBG measured at week 24\n\nData was not collected for patient 15 in clomiphene-anastrazole-placebo arm Data was not collected for patient 23 in placebo-clomiphene-anastrazole arm Data was not collected for patient 24 in placebo-anastrazole-clomiphene arm'}, {'type': 'SECONDARY', 'title': 'SEP #1-3 Cumulative - Screen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6'}, {'title': 'Patients 7-12'}, {'title': 'Patients 13-18'}, {'title': 'Patients 19-24'}], 'timeFrame': 'Baseline', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0', 'reportingStatus': 'POSTED', 'populationDescription': 'SEP measured at the initial encounter\n\nBaseline SPEP was not measured for participants 1-24\n\nTable included for completeness'}, {'type': 'SECONDARY', 'title': 'SEP #1-3 Cumulative - Week 8', 'denoms': [{'units': 'Participants', 'counts': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '2', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 8', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'SEP measured at the end of week 8\n\ndata not collected for pt 11,17 in PCA arm data not collected for pt 13 in ACP arm data not collected for pt 15 in CAP arm data not collected for pt 22 in CPA arm'}, {'type': 'SECONDARY', 'title': 'SEP #1-3 Cumulative - Week 16', 'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '4', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 16', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'SEP measured at the end of week 16\n\ndata not collected for pt 3,15 in CAP arm data not collected for pt 5,11,23 in PCA arm'}, {'type': 'SECONDARY', 'title': 'SEP #1-3 Cumulative - Week 24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '2', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}, {'value': '3', 'groupId': 'OG003'}, {'value': '2', 'groupId': 'OG004'}, {'value': '4', 'groupId': 'OG005'}]}], 'groups': [{'id': 'OG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'OG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'classes': [{'title': 'Patients 1-6', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG003'}, {'value': '3', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 7-12', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG005'}]}]}, {'title': 'Patients 13-18', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG003'}, {'value': '1', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '2', 'groupId': 'OG005'}]}]}, {'title': 'Patients 19-24', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '1', 'groupId': 'OG005'}]}], 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}, {'value': '1', 'groupId': 'OG005'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Week 24', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0', 'unitOfMeasure': 'score on a scale', 'reportingStatus': 'POSTED', 'populationDescription': 'SEP measured at the end of week 24 data not collected for pt 1,13 in ACP arm data not collected for pt 3, 15 in CAP arm data not collected for pt 22 in CPA arm data not collected for pt 11,23 PCA arm'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'FG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'FG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'FG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'FG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'FG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}], 'periods': [{'title': 'Baseline', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}]}]}, {'title': 'Baseline to Week 8', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}]}]}, {'title': 'Week 8 to Week 16', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}]}]}, {'title': 'Week 16 to Week 24', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '4'}, {'groupId': 'FG003', 'numSubjects': '4'}, {'groupId': 'FG004', 'numSubjects': '4'}, {'groupId': 'FG005', 'numSubjects': '4'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}]}]}], 'recruitmentDetails': 'Men will be incentivized to come to each clinic appointment with $20 dollars at the end. If they complete the study they will be able to earn $100. Men will be incentivized to not use phosphodiesterase inhibitors throughout the study by giving them three 100mg tablets of Viagra per month of the study for a total of twelve 100 mg tablets.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '4', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '24', 'groupId': 'BG006'}]}], 'groups': [{'id': 'BG000', 'title': 'Anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'BG001', 'title': 'Anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'BG002', 'title': 'Clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'BG003', 'title': 'Clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'BG004', 'title': 'Placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'BG005', 'title': 'Placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks\n\nAnastrozole 1mg\n\nClomiphene Citrate 25mg\n\nPlacebo - Cap'}, {'id': 'BG006', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Categorical', 'classes': [{'categories': [{'title': '<=18 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}]}, {'title': 'Between 18 and 65 years', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '24', 'groupId': 'BG006'}]}, {'title': '>=65 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}]}, {'title': 'Male', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '24', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '23', 'groupId': 'BG006'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'United States', 'categories': [{'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '4', 'groupId': 'BG005'}, {'value': '4', 'groupId': 'BG006'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2015-06-18', 'size': 208327, 'label': 'Study Protocol and Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'Prot_SAP_000.pdf', 'typeAbbrev': 'Prot_SAP', 'uploadDate': '2019-07-12T15:23', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'CROSSOVER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 24}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2015-04-02', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2019-10', 'completionDateStruct': {'date': '2017-03-08', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2019-10-26', 'studyFirstSubmitDate': '2019-04-29', 'resultsFirstSubmitDate': '2019-07-15', 'studyFirstSubmitQcDate': '2019-04-29', 'lastUpdatePostDateStruct': {'date': '2019-11-18', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2019-10-26', 'studyFirstPostDateStruct': {'date': '2019-05-01', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2019-11-18', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2017-03-08', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'IIEF (International Index of Erectile Function) Score - Screen', 'timeFrame': 'At baseline', 'description': '15 item self reported erectile function. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75'}, {'measure': 'IIEF (International Index of Erectile Function) Score - Week 8', 'timeFrame': 'Week 8', 'description': '15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75'}, {'measure': 'IIEF (International Index of Erectile Function) Score - Week 16', 'timeFrame': 'Week 16', 'description': '15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75'}, {'measure': 'IIEF (International Index of Erectile Function) Score - Week 24', 'timeFrame': 'Week 24', 'description': '15 item self reported erectile function over the past 8 weeks. Each item is scored 0-5 with 0=negative response and 5 = positive response with totals of 0-75'}], 'secondaryOutcomes': [{'measure': 'Normalized Testosterone - Screen', 'timeFrame': 'Baseline', 'description': 'Normalized at \\>350ng/dl'}, {'measure': 'Normalized Testosterone - Week 8', 'timeFrame': 'Week 8', 'description': 'Normalized at \\>350ng/dl'}, {'measure': 'Normalized Testosterone - Week 16', 'timeFrame': 'Week 16', 'description': 'Normalized at \\>350ng/dl'}, {'measure': 'Normalized Testosterone - Week 24', 'timeFrame': 'Week 24', 'description': 'Normalized at \\>350ng/dl'}, {'measure': 'ADAM (Androgen Deficiency in the Aging Male) Score - Screen', 'timeFrame': 'Baseline', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0'}, {'measure': 'ADAM (Androgen Deficiency in the Aging Male) Score - Week 8', 'timeFrame': 'Week 8', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0'}, {'measure': 'ADAM (Androgen Deficiency in the Aging Male) Score - Week 16', 'timeFrame': 'Week 16', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0'}, {'measure': 'ADAM (Androgen Deficiency in the Aging Male) Score - Week 24', 'timeFrame': 'Week 24', 'description': 'Self reported quantification of hypogonadism. 10 "yes" or "no" questions.\n\nA positive (yes) questionnaire result is defined as a "yes or 1" and a negative (no) questionnaire result is defined as a "no or 0" to question 1 or question 7 or any 3 other questions.\n\nYes (1) represents a better outcome than No (1)\n\nIn Data Entry:\n\nYes - 1 No - 0'}, {'measure': 'EHS (Erectile Hardness Score) - Screen', 'timeFrame': 'Baseline', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid'}, {'measure': 'EHS (Erectile Hardness Score) - Week 8', 'timeFrame': 'Week 8', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid'}, {'measure': 'EHS (Erectile Hardness Score) - Week 16', 'timeFrame': 'Week 16', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid'}, {'measure': 'EHS (Erectile Hardness Score) - Week 24', 'timeFrame': 'Week 24', 'description': 'Self reported questionnaire rated 0-4 0=penis does not enlarge, 4=Penis completely hard and fully rigid'}, {'measure': 'LH - Screen', 'timeFrame': 'Baseline', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.'}, {'measure': 'LH - Week 8', 'timeFrame': 'Week 8', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.'}, {'measure': 'LH - Week 16', 'timeFrame': 'Week 16', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.'}, {'measure': 'LH - Week 24', 'timeFrame': 'Week 24', 'description': 'Luteinizing Hormone levels collected at the initial encounter and at the end of the 8, 16, and 24 week periods.'}, {'measure': 'FSH - Screen', 'timeFrame': 'Baseline', 'description': 'Lab Values for follicle stimulating hormone'}, {'measure': 'FSH - Week 8', 'timeFrame': 'Week 8', 'description': 'Lab Values for follicle stimulating hormone'}, {'measure': 'FSH - Week 16', 'timeFrame': 'Week 16', 'description': 'Lab Values for follicle stimulating hormone'}, {'measure': 'FSH - Week 24', 'timeFrame': 'Week 24', 'description': 'Lab Values for follicle stimulating hormone'}, {'measure': 'Free Testosterone - Screen', 'timeFrame': 'Baseline', 'description': 'Measure of Free Testosterone'}, {'measure': 'Free Testosterone - Week 8', 'timeFrame': 'Week 8', 'description': 'Measure of Free Testosterone'}, {'measure': 'Free Testosterone - Week 16', 'timeFrame': 'Week 16', 'description': 'Measure of Free Testosterone'}, {'measure': 'Free Testosterone - Week 24', 'timeFrame': 'Week 24', 'description': 'Measure of Free Testosterone'}, {'measure': 'Estradiol - Screen', 'timeFrame': 'Baseline', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24'}, {'measure': 'Estradiol - Week 8', 'timeFrame': 'Week 8', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was \\<5'}, {'measure': 'Estradiol - Week 16', 'timeFrame': 'Week 16', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was \\<5'}, {'measure': 'Estradiol - Week 24', 'timeFrame': 'Week 24', 'description': 'Measurement of Estradiol levels at initial encounter and at the end of Weeks 8, 16, and 24 An entered value of 4.9 means the measure was \\<5'}, {'measure': 'SHBG - Screen', 'timeFrame': 'Baseline', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24'}, {'measure': 'SHBG - Week 8', 'timeFrame': 'Week 8', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24'}, {'measure': 'SHBG - Week 16', 'timeFrame': 'Week 16', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24'}, {'measure': 'SHBG - Week 24', 'timeFrame': 'Week 24', 'description': 'Lab Measure of sex hormone binding globulin at the initial encounter and at the ends of week 8, 16, and 24'}, {'measure': 'SEP #1-3 Cumulative - Screen', 'timeFrame': 'Baseline', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0'}, {'measure': 'SEP #1-3 Cumulative - Week 8', 'timeFrame': 'Week 8', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0'}, {'measure': 'SEP #1-3 Cumulative - Week 16', 'timeFrame': 'Week 16', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0'}, {'measure': 'SEP #1-3 Cumulative - Week 24', 'timeFrame': 'Week 24', 'description': 'Questions 1, 2, and 3 for the Sexual Encounter Profile have been cumulatively added. 1 - yes and 0 - no have been added for questions 1-3 to determine a total value from 0-3.\n\n0-3: cumulative score from SEP questions 1, 2, and 3\n\nHigher values (3) are considered to be a better outcomes relative to lower numbers (0) 3 is better than 2 is better than 1 is better than 0'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Hypogonadism, Male']}, 'descriptionModule': {'briefSummary': 'This study evaluates anastrazole and clomiphene in the improvement in hypogonadal symptoms and erectile function. Each subject will receive Anastrazole 1 mg/day, clomiphene 25 mg/day and placebo in randomized schedule of 8 week intervals.', 'detailedDescription': 'Aromatase inhibitors (AI) (Anastrazole) and selective estrogen receptor modifiers (SERMS)(clomiphene) increase testosterone production through stimulation of the hypothalamic pituitary axis. While these drugs both reduce the feedback inhibition of estrogen on the pituitary, SERMs cause an increase in serum estradiol, whereas AIs reduce estradiol levels. Using these medications, we can obtain therapeutic testosterone levels with either an increase or decrease in estradiol levels.'}, 'eligibilityModule': {'sex': 'MALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Men age 18-70\n2. Baseline morning Testosterone 150-350 ng/dL x2\n3. leutenizing hormone (LH) 1.5-9.2 miU/mL, Follicle stimulation hormone (FSH) 1.6-8.0 miU/mL, Prolactin 4-15 ng/mL\n4. Positive Androgen Deficiency in the Aging Male (ADAM) score. A positive score is when an affirmative answer (\'\'yes\'\') to either questions "Do you have a decreased sex drive/libido?" or "Are your erections less strong?" or any three other questions.10\n5. Body mass index (BMI) \\<40\n6. Sexual health inventory for men (SHIM) score \\>7 and \\<21. Patients are allowed to be taking phosphodiesterase 5 inhibitors (i.e. Viagra, Levitra, Cialis) at baseline, however we will ask them to do the SHIM survey as if they were not taking this medication.\n7. Men must attempt to have at least four sexual encounters over each of the eight-week periods\n8. Men willing not to take phosphodiesterase 5 inhibitors throughout the entire study\n\nExclusion Criteria:\n\n1. Current or previous history of prostate cancer\n2. Previous or current androgen deprivation therapy for prostate cancer,\n3. Past surgical history of prostatectomy.\n4. History of testicular cancer.\n5. History of deep vein thrombosis (DVT) or blood dyscrasia\n6. History of breast cancer\n7. Men with past or current treatment for erectile dysfunction including MUSE (alprostodil), intracavernosal injections, penile prosthesis. Men not on treatment or men who are on phosphodiesterase inhibitors will be allowed to be in the study but must stop their use at the screening visit.\n8. Chronic opioid use\n9. Use of steroids within the past 3 months, including prednisone and/or cortisone injections, and inhaled steroids. Topical steroid cream is acceptable.\n10. History of or current use of anabolic steroids, i.e. testosterone, (or any analog of testosterone) dihydroepiandrosterone (DHEA), dihydroepiandrosterone sulfate (DHEAS) or any growth promoters i.e. growth hormone itself or analogs of growth hormone\n11. History of or current use of anti-androgen medications, i.e. Aldactone, Tagamet, estrogens\n12. Alcohol intake \\> 30 grams (drink more than 2 beers per day OR more than 1 glass of wine or cocktail daily)\n13. Having started a new medication during the past three months which may interfere with the outcome measures of the study\n14. Polycythemia (HCT \\>52% )\n15. History of prostate specific antigen (PSA)\\> 4.0 ng/dl\n16. Hematocrit (HCT)\\< 36 %\n17. Liver function tests greater than 2 times upper normal limits or history of abnormal electrolytes, calcium or Parathyroid hormone without workup, at the discretion of the investigator.\n18. Previous hypogonadal treatment within last 3 months. -'}, 'identificationModule': {'nctId': 'NCT03933618', 'acronym': 'CAP', 'briefTitle': 'Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function', 'organization': {'class': 'OTHER', 'fullName': 'Albany Medical College'}, 'officialTitle': 'A Randomized Double Blinded Placebo Controlled Trial Between Anastrozole and Clomiphene to Evaluate Improvement in Hypogonadal Symptoms and Erectile Function Using ADAM, IIEF and EHS Validated Scales', 'orgStudyIdInfo': {'id': '4134'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'OTHER', 'label': 'anastrazole-clomiphene-placebo', 'description': 'anastrozole for eight weeks then clomiphene for eight weeks then placebo for eight weeks', 'interventionNames': ['Drug: Anastrozole 1mg', 'Drug: Clomiphene Citrate 25mg', 'Drug: Placebo - Cap']}, {'type': 'OTHER', 'label': 'anastrazole-placebo-clomiphene', 'description': 'anastrozole for eight weeks then placebo for eight weeks then clomiphene for eight weeks', 'interventionNames': ['Drug: Anastrozole 1mg', 'Drug: Clomiphene Citrate 25mg', 'Drug: Placebo - Cap']}, {'type': 'OTHER', 'label': 'clomiphene-anastrazole-placebo', 'description': 'clomiphene for eight weeks then anastrozole for eight weeks then placebo for eight weeks', 'interventionNames': ['Drug: Anastrozole 1mg', 'Drug: Clomiphene Citrate 25mg', 'Drug: Placebo - Cap']}, {'type': 'OTHER', 'label': 'clomiphene-placebo-anastrazole', 'description': 'clomiphene for eight weeks then placebo for eight weeks then anastrozole for eight weeks', 'interventionNames': ['Drug: Anastrozole 1mg', 'Drug: Clomiphene Citrate 25mg', 'Drug: Placebo - Cap']}, {'type': 'OTHER', 'label': 'placebo-clomiphene-anastrazole', 'description': 'placebo for eight weeks then clomiphene for eight weeks then anastrozole for eight weeks', 'interventionNames': ['Drug: Anastrozole 1mg', 'Drug: Clomiphene Citrate 25mg', 'Drug: Placebo - Cap']}, {'type': 'OTHER', 'label': 'placebo-anastrazole-clomiphene', 'description': 'placebo for eight weeks then anastrozole for eight weeks then clomiphene for eight weeks', 'interventionNames': ['Drug: Anastrozole 1mg', 'Drug: Clomiphene Citrate 25mg', 'Drug: Placebo - Cap']}], 'interventions': [{'name': 'Anastrozole 1mg', 'type': 'DRUG', 'armGroupLabels': ['anastrazole-clomiphene-placebo', 'anastrazole-placebo-clomiphene', 'clomiphene-anastrazole-placebo', 'clomiphene-placebo-anastrazole', 'placebo-anastrazole-clomiphene', 'placebo-clomiphene-anastrazole']}, {'name': 'Clomiphene Citrate 25mg', 'type': 'DRUG', 'armGroupLabels': ['anastrazole-clomiphene-placebo', 'anastrazole-placebo-clomiphene', 'clomiphene-anastrazole-placebo', 'clomiphene-placebo-anastrazole', 'placebo-anastrazole-clomiphene', 'placebo-clomiphene-anastrazole']}, {'name': 'Placebo - Cap', 'type': 'DRUG', 'armGroupLabels': ['anastrazole-clomiphene-placebo', 'anastrazole-placebo-clomiphene', 'clomiphene-anastrazole-placebo', 'clomiphene-placebo-anastrazole', 'placebo-anastrazole-clomiphene', 'placebo-clomiphene-anastrazole']}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Robert C Welliver, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Albany Medical College'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Albany Medical College', 'class': 'OTHER'}, 'collaborators': [{'name': 'Laboratory Corporation of America', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}}